ETF Managers Group’s West Pharmaceutical WST Stock Holding History

ETF Managers Group’s Portfolio WST Stock Details WST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	$609K	Buy	1,759 +26	+2%	+$7.6K	0.02%	394
2022 Q4	$408K	Buy	1,733 +63	+4%	+$14.9K	0.02%	398
2022 Q3	$411K	Buy	1,670 +65	+4%	+$19.8K	0.01%	497
2022 Q2	$481K	Sell	1,605 -865	-35%	-$281K	0.01%	507
2022 Q1	$1.03M	Buy	2,470 +46	+2%	+$18K	0.02%	277
2021 Q4	$1.14M	Buy	2,424 +114	+5%	+$49.1K	0.02%	261
2021 Q3	$999K	Sell	2,310 -3,856	-63%	-$1.63M	0.02%	270
2021 Q2	$2.22M	Buy	+6,166	New	+$2.04M	0.04%	214

Other funds holding WST

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

APG Asset Management Amsterdam, Netherlands $40.7B AUM 39.97% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

ETF Managers Group's WST Position: Q1 2023 in Review

ETF Managers Group increased its West Pharmaceutical (WST) stake by 1.5% in Q1 2023, buying an estimated $7.6K and bringing the position to 1,759 shares worth $609K. The position accounts for 0.02% of the portfolio, ranked #394.

ETF Managers Group first reported a position in WST in Q2 2021 and has held it in 8 quarters since. The position peaked at $2.22M in Q2 2021. 695 funds tracked by Wall St. Rank hold WST as of Q1 2023.

ETF Managers Group held 1,759 shares of West Pharmaceutical worth $609K as of Q1 2023.
ETF Managers Group bought 26 West Pharmaceutical shares in Q1 2023, an estimated $7.6K.
West Pharmaceutical made up 0.02% of ETF Managers Group's portfolio in Q1 2023, its #394 holding.
ETF Managers Group first reported a position in West Pharmaceutical in Q2 2021 and has held it in 8 quarters since.
ETF Managers Group's West Pharmaceutical position peaked at $2.22M in Q2 2021.
695 funds tracked by Wall St. Rank held West Pharmaceutical as of Q1 2023.

Based on ETF Managers Group's 13F filing for Q1 2023, filed 18 Apr 2023.